> top > docs > PMC:1892049 > spans > 15944-16406 > annotations

PMC:1892049 / 15944-16406 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T16234 34-39 PR_EXT:000009158 denotes ITPR1
T16235 50-53 NCBITaxon:10376 denotes EBV
T16236 67-78 CL:0000542 denotes lymphocytes
T16237 126-131 PR_EXT:000009158 denotes ITPR1
T16238 132-140 SO_EXT:sequence_deletion_entity_or_process denotes deletion
T16239 221-229 SO_EXT:sequence_deletion_entity_or_process denotes deletion
T16240 270-275 PR_EXT:000009158 denotes ITPR1
T16241 276-284 SO_EXT:sequence_deletion_entity_or_process denotes deletion
T16242 313-318 PR_EXT:000009158 denotes ITPR1
T16243 440-448 GO:0042571 denotes antibody
T16244 457-461 PR_EXT:000003676 denotes ACTB

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T16223 34-39 PR:000009158 denotes ITPR1
T16224 50-53 NCBITaxon:10376 denotes EBV
T16225 67-78 CL:0000542 denotes lymphocytes
T16226 126-131 PR:000009158 denotes ITPR1
T16227 270-275 PR:000009158 denotes ITPR1
T16228 313-318 PR:000009158 denotes ITPR1
T16229 440-448 GO:0042571 denotes antibody
T16230 457-461 PR:000003676 denotes ACTB

craft-sa-dev

Id Subject Object Predicate Lexical cue
T16261 0-7 NNP denotes Western
T16262 8-12 NN denotes blot
T16263 13-22 VBN denotes performed
T16264 23-25 TO denotes to
T16265 26-33 VB denotes examine
T16266 34-39 NN denotes ITPR1
T16267 40-46 NNS denotes levels
T16268 47-49 IN denotes in
T16269 50-53 NN denotes EBV
T16270 67-78 NNS denotes lymphocytes
T16271 54-66 VBN denotes immortalized
T16272 79-83 IN denotes from
T16273 84-88 NN denotes AUS1
T16274 89-97 VBN denotes affected
T16275 105-112 NNS denotes members
T16276 98-104 NN denotes family
T16277 113-121 VBG denotes carrying
T16278 122-125 DT denotes the
T16279 132-140 NN denotes deletion
T16280 126-131 NN denotes ITPR1
T16281 141-144 CC denotes and
T16282 145-149 IN denotes from
T16283 150-152 DT denotes an
T16284 165-171 NN denotes member
T16285 153-157 NN denotes AUS1
T16286 158-164 NN denotes family
T16287 172-174 IN denotes of
T16288 175-182 JJ denotes unknown
T16289 191-197 NN denotes status
T16290 183-190 NN denotes disease
T16291 198-201 WP denotes who
T16292 211-216 VB denotes carry
T16293 202-206 VBZ denotes does
T16294 207-210 RB denotes not
T16295 217-220 DT denotes the
T16296 221-229 NN denotes deletion
T16297 229-230 . denotes .
T16298 230-326 sentence denotes Notably the samples from patients with ITPR1 deletion show a dramatic decrease in ITPR1 levels.
T16299 231-238 RB denotes Notably
T16300 285-289 VBP denotes show
T16301 239-242 DT denotes the
T16302 243-250 NNS denotes samples
T16303 251-255 IN denotes from
T16304 256-264 NNS denotes patients
T16305 265-269 IN denotes with
T16306 270-275 NN denotes ITPR1
T16307 276-284 NN denotes deletion
T16308 290-291 DT denotes a
T16309 301-309 NN denotes decrease
T16310 292-300 JJ denotes dramatic
T16311 310-312 IN denotes in
T16312 313-318 NN denotes ITPR1
T16313 319-325 NNS denotes levels
T16314 325-326 . denotes .
T16315 326-462 sentence denotes To demonstrate equal loading, these samples were diluted one in five, and the Western blot was repeated using an antibody against ACTB.
T16316 327-329 TO denotes To
T16317 330-341 VB denotes demonstrate
T16318 376-383 VBN denotes diluted
T16319 342-347 JJ denotes equal
T16320 348-355 NN denotes loading
T16321 355-357 , denotes ,
T16322 357-362 DT denotes these
T16323 363-370 NNS denotes samples
T16324 371-375 VBD denotes were
T16325 384-387 CD denotes one
T16326 388-390 IN denotes in
T16327 391-395 CD denotes five
T16328 395-397 , denotes ,
T16329 397-400 CC denotes and
T16330 401-404 DT denotes the
T16331 413-417 NN denotes blot
T16332 405-412 NNP denotes Western
T16333 422-430 VBN denotes repeated
T16334 418-421 VBD denotes was
T16335 431-436 VBG denotes using
T16336 437-439 DT denotes an
T16337 440-448 NN denotes antibody
T16338 449-456 IN denotes against
T16339 457-461 NN denotes ACTB
T16340 461-462 . denotes .
R4862 T16261 T16262 compound Western,blot
R4863 T16263 T16262 acl performed,blot
R4864 T16264 T16265 aux to,examine
R4865 T16265 T16263 advcl examine,performed
R4866 T16266 T16267 compound ITPR1,levels
R4867 T16267 T16265 dobj levels,examine
R4868 T16268 T16267 prep in,levels
R4869 T16269 T16270 nmod EBV,lymphocytes
R4870 T16270 T16268 pobj lymphocytes,in
R4871 T16271 T16270 amod immortalized,lymphocytes
R4872 T16272 T16270 prep from,lymphocytes
R4873 T16273 T16274 npadvmod AUS1,affected
R4874 T16274 T16275 amod affected,members
R4875 T16275 T16272 pobj members,from
R4876 T16276 T16275 compound family,members
R4877 T16277 T16275 acl carrying,members
R4878 T16278 T16279 det the,deletion
R4879 T16279 T16277 dobj deletion,carrying
R4880 T16280 T16279 compound ITPR1,deletion
R4881 T16281 T16272 cc and,from
R4882 T16282 T16272 conj from,from
R4883 T16283 T16284 det an,member
R4884 T16284 T16282 pobj member,from
R4885 T16285 T16284 compound AUS1,member
R4886 T16286 T16284 compound family,member
R4887 T16287 T16284 prep of,member
R4888 T16288 T16289 amod unknown,status
R4889 T16289 T16287 pobj status,of
R4890 T16290 T16289 compound disease,status
R4891 T16291 T16292 dep who,carry
R4892 T16292 T16284 relcl carry,member
R4893 T16293 T16292 aux does,carry
R4894 T16294 T16292 neg not,carry
R4895 T16295 T16296 det the,deletion
R4896 T16296 T16292 dobj deletion,carry
R4897 T16297 T16262 punct .,blot
R4898 T16299 T16300 advmod Notably,show
R4899 T16301 T16302 det the,samples
R4900 T16302 T16300 nsubj samples,show
R4901 T16303 T16302 prep from,samples
R4902 T16304 T16303 pobj patients,from
R4903 T16305 T16304 prep with,patients
R4904 T16306 T16307 compound ITPR1,deletion
R4905 T16307 T16305 pobj deletion,with
R4906 T16308 T16309 det a,decrease
R4907 T16309 T16300 dobj decrease,show
R4908 T16310 T16309 amod dramatic,decrease
R4909 T16311 T16309 prep in,decrease
R4910 T16312 T16313 compound ITPR1,levels
R4911 T16313 T16311 pobj levels,in
R4912 T16314 T16300 punct .,show
R4913 T16316 T16317 aux To,demonstrate
R4914 T16317 T16318 advcl demonstrate,diluted
R4915 T16319 T16320 amod equal,loading
R4916 T16320 T16317 dobj loading,demonstrate
R4917 T16321 T16318 punct ", ",diluted
R4918 T16322 T16323 det these,samples
R4919 T16323 T16318 nsubjpass samples,diluted
R4920 T16324 T16318 auxpass were,diluted
R4921 T16325 T16318 npadvmod one,diluted
R4922 T16326 T16325 prep in,one
R4923 T16327 T16326 pobj five,in
R4924 T16328 T16318 punct ", ",diluted
R4925 T16329 T16318 cc and,diluted
R4926 T16330 T16331 det the,blot
R4927 T16331 T16333 nsubjpass blot,repeated
R4928 T16332 T16331 compound Western,blot
R4929 T16333 T16318 conj repeated,diluted
R4930 T16334 T16333 auxpass was,repeated
R4931 T16335 T16333 advcl using,repeated
R4932 T16336 T16337 det an,antibody
R4933 T16337 T16335 dobj antibody,using
R4934 T16338 T16337 prep against,antibody
R4935 T16339 T16338 pobj ACTB,against
R4936 T16340 T16318 punct .,diluted